fashion -WSS

fashion

author：entertainment 2025-10-02 08:57:23 - browse：792

A product image of the Cue reader COVID-19 home use test — Businesswire via AP

The Food and Drug Administration warned consumers Monday to not use Cue Health’s at-home Covid-19 tests. This follows an FDA warning letter to the company last week that said Cue was not following the conditions stipulated in the emergency use authorizations for its tests.

The FDA letters said the tests could give false results. Specifically, the agency said that the company had changed how the electrochemical signals within the test device were generated, received, and interpreted — changes the FDA has not authorized. These changes decreased the stability of the tests and might lead to false results, the agency said.

The FDA warnings come near what might be the end of a spectacularly bumpy ride for the company. When Cue went public in 2021, it was valued at nearly $3 billion. It supplied tests for the NBA’s 2020 “bubble,” leading a Trump administration official to proclaim that if the test was “good enough for LeBron,” the administration would bring it to the American people — and it did, in a $481 million deal.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Why don't Americans have at

WSS

Abbott's new heart device gets FDA advisory panel nod

Cancer cells are shown to suck energy source from immune cells

AMAs digital advisors table RPM coding reform proposal, again

Readout LOUD podcast: Merger Mondays, Ozempic panic

Having children helps parents live longer, especially after age 80

Researchers CRISPR chickens in bid to protect them from bird flu

focus

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

entertainment

Heart attack and stroke risk calculators need revising

Having children helps parents live longer, especially after age 80

Walensky prepares to leave CDC — and Congress — behind

Why Eli Lilly’s earnings didn’t quite live up to the hype

Anesthesiologist group: stop taking Ozempic before surgery

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

Apple is now the first public company to be valued at $3 trillion

STAT Readout Newsletter: Today in biotech, life science news

23andMe had bad news about my health. I wish a person had delivered it

Cancer cells are shown to suck energy source from immune cells

Wikipedia

European regulators consider appeal over Amylyx ALS drug

Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO

Bernie Sanders bashes nonprofit hospitals over their tax breaks

Nick Jonas talks about managing diabetes along with his career

Readout Newsletter: Amylyx, Aurinia, and IQVIA

Wellcome Trust names Røttingen as its new CEO

focus

focus

entertainment

entertainment